Ocugen to commercialise Covaxin in Mexico

City-based pharma major Bharat Biotech’s US partner Ocugen, Inc. has got the permission to commercialise  Covid vaccine Covaxin in Mexico.

Published: 19th April 2022 05:50 AM  |   Last Updated: 19th April 2022 05:50 AM   |  A+A-

Covid, Coronavirus, Covid vaccine, Monoclonal antibody therapy

Image used for representational purpose only. (File Photo)

By Express News Service

HYDERABAD: City-based pharma major Bharat Biotech’s US partner Ocugen, Inc. has got permission to commercialise the Covid vaccine Covaxin in Mexico. With this, the company has rights of Covaxin for all of North America. Covaxin previously had already been authorized for emergency use in adults by health regulators in Mexico, and now the biotechnology firm has submitted request for Emergency Use Authorization (EUA) for children aged 2-18 years.

Ocugen, Inc. and (Bharat Biotech) BBIL, on Monday announced that they have entered into an amendment to their Co-development, Supply and Commercialization Agreement to expand Ocugen’s exclusive territory to include commercialization of COVAXINT in Mexico.  

“After meeting with Mexico’s Secretary of Foreign Affairs, Marcelo Ebrard, in Delhi, we are encouraged by the role COVAXINTM can play in Mexico’s continuing efforts to defeat the COVID-19 pandemic. COVAXINT is currently under review by COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) for emergency use among children between 2 and 18 years of age, and Ocugen is prepared to collaborate with the public health community to help their efforts. We also thank Bharat Biotech for helping make this opportunity a reality,” said Dr Shankar Musunuri, Chairman of the Board, Chief Executive Officer and Co-founder of Ocugen, Inc.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp